Key result
A sudden upsurge in neonatal enteroviral myocarditis cases in the UK has prompted a WHO advisory to consider myocarditis and test for enteroviruses in neonates presenting with shock.
Why the study?
A sudden upsurge in neonatal enteroviral myocarditis cases reported from South West England and South Wales alerted health agencies to introduce counteracting measures.
Alerts clinicians to a recent cluster of neonatal enteroviral myocarditis in the UK and highlights the WHO advisory to test for enteroviruses in neonates presenting with shock.
Raises suspicion for enteroviral myocarditis in neonates with shock; leaves open need for surveillance and prevention studies.
Objectives: Neonatal myocarditis is a rare but life-threatening complication of enterovirus infection that presents like bacterial sepsis. Outbreak: A sudden upsurge in cases of neonatal enteroviral myocarditis, reported from South West England and South Wales between June 2022 and April 2023 has alerted health agencies to bring in counteracting measures. Impact: In view of this outbreak situation, the World Health Organisation advisory has urged clinicians seeing neonates and infants with shock may consider myocarditis as a differential diagnosis and test for enteroviruses.
No takes yet. Share an insight, caveat, or question.
Pattanaik et al. (2024) studied Neonatal enteroviral myocarditis. Enterovirus infection was evaluated. A sudden upsurge in neonatal enteroviral myocarditis cases in the UK has prompted a WHO advisory to consider myocarditis and test for enteroviruses in neonates presenting with shock.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: